Shkreli Can't Press Pause On $64M Antitrust Judgment

By Nadia Dreid · March 18, 2022, 6:17 PM EDT

Disgraced former pharmaceutical executive Martin Shkreli can't put off paying a $64.6 million antitrust judgment against him while he fights it in a higher court, a New York federal judge has...

To view the full article, register now.

Try a seven day FREE Trial

Already a subscriber? Click here to login

Documents

Order

Case Information

Case Title

Federal Trade Commission et al v. Vyera Pharmaceuticals, LLC et al

Case Number

Court

New York Southern

Nature of Suit

Banks and Banking

Date Filed

January 27, 2020

Recent Articles By Nadia

December 10, 2024
Judge Won't Cull EpiPen Antitrust Action Against Mylan
November 19, 2024
DC Circ. Wonders Where To Land On Terrorism Liability Claims
November 07, 2024
Sutter Health Could Face Retrial On Antitrust Claims In March
July 17, 2024
Teladoc Hit With Another Investor Suit Over BetterHelp Woes
July 11, 2024
Pfizer's $50M EpiPen Deal Gets Final OK In Antitrust Suit
June 27, 2024
Judge OKs $10M Deal In Generic Price-Fixing MDL
April 16, 2024
NC Treasurer Backs FTC On Hospital Merger Challenge
April 09, 2024
White House, Senate Dems Want $1.3B To Fight COVID Fraud
March 01, 2024
NY Judge Tosses $6.4B BMS Investor Action For Good
February 21, 2024
39 AGs Call For Federal Pharmacy Benefit Manager Reform